GRP78 Is a Targetable Receptor on Cancer and Stromal Cells

por Araujo, Nathalia, Hebbar, Nikhil, Rangnekar, Vivek M.
Publicado 2018

Par-4 prevents breast cancer recurrence

por Hebbar, Nikhil, Shrestha-Bhattarai, Tripti, Rangnekar, Vivek M
Publicado 2013

Value added by an inter-continental cancer consortium

por Rao, Mahadev, Venkatraman, Prasanna, Mukhopadhyay, Debabrata, Roychoudhury, Susanta, Vanderford, Nathan L., Rangnekar, Vivek M.
Publicado 2021

Develop a High-Throughput Screening Method to Identify C-P4H1 (Collagen Prolyl 4-Hydroxylase 1) Inhibitors from FDA-Approved Chemicals

por Wang, Shike, Lee, Kuo-Hao, Araujo, Nathalia Victoria, Zhan, Chang-Guo, Rangnekar, Vivek M., Xu, Ren
Publicado 2020

Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors

por Wang, Peng, Burikhanov, Ravshan, Jayswal, Rani, Weiss, Heidi L., Arnold, Susanne M., Villano, John L., Rangnekar, Vivek M.
Publicado 2018

Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells

por PEREIRA, MICHELLY C., DE BESSA-GARCIA, SIMONE A., BURIKHANOV, RAVSHAN, PAVANELLI, ANA CAROLINA, ANTUNES, LOURIVAL, RANGNEKAR, VIVEK M., NAGAI, MARIA A.
Publicado 2013

Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways

por Ding, Na, Jiang, Hong, Thapa, Pratik, Hao, Yanning, Alshahrani, Aziza, Allison, Derek, Izumi, Tadahide, Rangnekar, Vivek M., Liu, Xiaoqi, Wei, Qiou
Publicado 2022

Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells

por Sarkar, Shayan, Jain, Sumeet, Rai, Vineeta, Sahoo, Dipak K., Raha, Sumita, Suklabaidya, Sujit, Senapati, Shantibhusan, Rangnekar, Vivek M., Maiti, Indu B., Dey, Nrisingha
Publicado 2015

Radiation Induced Apoptosis of Murine Bone Marrow Cells Is Independent of Early Growth Response 1 (EGR1)

por Oben, Karine Z., Gachuki, Beth W., Alhakeem, Sara S., McKenna, Mary K., Liang, Ying, St. Clair, Daret K., Rangnekar, Vivek M., Bondada, Subbarao
Publicado 2017

Arylquins Target Vimentin to Trigger Par-4 Secretion for Tumor Cell Apoptosis

por Burikhanov, Ravshan, Sviripa, Vitaliy M., Hebbar, Nikhil, Zhang, Wen, Layton, W. John, Hamza, Adel, Zhan, Chang-Guo, Watt, David S., Liu, Chunming, Rangnekar, Vivek M.
Publicado 2014

Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers

por Kolesar, Jill, Peh, Spencer, Thomas, Levin, Baburaj, Gayathri, Mukherjee, Nayonika, Kantamneni, Raveena, Lewis, Shirley, Pai, Ananth, Udupa, Karthik S., Kumar AN, Naveena, Rangnekar, Vivek M., Rao, Mahadev
Publicado 2022

Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer

por Parida, Preetiparna, Lewis, Shirley, Sharan, Krishna, Kamal, Mehta Vedant, Kumar, Naveena A. N., Godkhindi, Vishwapriya M., Varambally, Sooryanarayana, Rangnekar, Vivek M., Rao, Mahadev, Damerla, Rama Rao
Publicado 2023

Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis

por Burikhanov, Ravshan, Hebbar, Nikhil, Noothi, Sunil K., Shukla, Nidhi, Sledziona, James, Araujo, Nathália, Kudrimoti, Meghana, Wang, Qing Jun, Watt, David S., Welch, Danny R., Maranchie, Jodi, Harada, Akihiro, Rangnekar, Vivek M.
Publicado 2017

Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents

por Hammill, Jared T., Sviripa, Vitaliy M., Kril, Liliia M., Ortiz, Diana, Fargo, Corinne M., Kim, Ho Shin, Chen, Yizhe, Rector, Jonah, Rice, Amy L., Domagalska, Malgorzata A., Begley, Kristin L., Liu, Chunming, Rangnekar, Vivek M., Dujardin, Jean-Claude, Watt, David S., Landfear, Scott M., Guy, R. Kiplin
Publicado 2021

Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

por Araujo, Nathalia, Sledziona, James, Noothi, Sunil K., Burikhanov, Ravshan, Hebbar, Nikhil, Ganguly, Saptadwipa, Shrestha-Bhattarai, Tripti, Zhu, Beibei, Katz, Wendy S., Zhang, Yi, Taylor, Barry S., Liu, Jinze, Chen, Li, Weiss, Heidi L., He, Daheng, Wang, Chi, Morris, Andrew J., Cassis, Lisa A., Nikolova-Karakashian, Mariana, Nagareddy, Prabhakar R., Melander, Olle, Evers, B. Mark, Kern, Philip A., Rangnekar, Vivek M.
Publicado 2022